Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ad-hoc News: Salzgitter Aktiengesellschaft (EQS) +++ SALZGITTER Aktie +4,83%

LABCORP Aktie

 >LABCORP Aktienkurs 
328 EUR    +10.1%    (TradegateBSX)
Ask: 330 EUR / 30 Stück
Bid: 328 EUR / 30 Stück
Tagesumsatz: 47 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
LABCORP Aktie über LYNX handeln
>LABCORP Performance
1 Woche: +3,5%
1 Monat: +9,6%
3 Monate: +13,7%
6 Monate: +32,4%
1 Jahr: +24,2%
laufendes Jahr: +39,3%
>LABCORP Aktie
Name:  LABCORP HLDGS INC. O.N.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US5049221055 / A40C39
Symbol/ Ticker:  N6B (Frankfurt) / LH (NYSE)
Kürzel:  FRA:N6B, ETR:N6B, N6B:GR, NYSE:LH
Index:  -
Profil:  Labcorp Holdings Inc. is a global life sciences and healthcare company that provides laboratory services to support clinical care, research, and drug development. Labcorp Holdings Inc. serves doctors, hospitals, pharmaceutical companies, researchers,..
>Volltext..
Marktkapitalisierung:  23814.61 Mio. EUR
Unternehmenswert:  29636.86 Mio. EUR
Umsatz:  12808.08 Mio. EUR
EBITDA:  2075.82 Mio. EUR
Nettogewinn:  894.73 Mio. EUR
Gewinn je Aktie:  10.86 EUR
Schulden:  6039.92 Mio. EUR
Liquide Mittel:  126.58 Mio. EUR
Operativer Cashflow:  1462.56 Mio. EUR
Bargeldquote:  0.07
Umsatzwachstum:  9.76%
Gewinnwachstum:  35.42%
Dividende je Aktie:  2.47 EUR
Dividendenrendite:  0.88%
Dividendenschätzung:  0.87%
Div. Historie:  28.08.26 - 0.617976€
29.05.26 - 0.617976€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  LABCORP
Letzte Datenerhebung:  28.10.26
>LABCORP Kennzahlen
Aktien/ Unternehmen:
Aktien: 81.1 Mio. St.
Frei handelbar: 99.6%
Rückkaufquote: 2.39%
Mitarbeiter: 71000
Umsatz/Mitarb.: 0.18 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 6.24%
Bewertung:
KGV: 27.58
KGV lG: 17.85
KUV: 1.82
KBV: 3.13
PEG-Ratio: 0.79
EV/EBITDA: 14.28
Rentabilität:
Bruttomarge: 26.82%
Gewinnmarge: 6.99%
Operative Marge: 11.35%
Managementeffizenz:
Gesamtkaprendite: 5.48%
Eigenkaprendite: 11.74%
>LABCORP Peer Group
Gesundheit, Neurologische Erkrankungen/ Schlaganfälle, Autoimmunerkrankungen, Onkologie/ Krebs- Behandlung
 
28.10.26 - 17:24
Stocks making the biggest moves midday: Wendys, Wingstop, F5, Enphase Energy, Labcorp & more (CNBC)
 
Here are some of the companies making headlines in midday trading....
28.10.26 - 17:15
LH Stock Rises on Q3 Earnings and Revenue Beat, ′26 View Up (Zacks)
 
Labcorp shares rise as Q3 earnings and revenues beat estimates, both segments deliver growth, margins expand and the company raises its 2026 financial outlook....
28.10.26 - 15:45
Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics (Zacks)
 
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
28.10.26 - 15:24
Earnings Call: Labcorp übertrifft Prognosen für Q3 2026 und hebt Ausblick an (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
28.10.26 - 15:01
Labcorp Holdings (LH) Q3 Earnings and Revenues Surpass Estimates (Zacks)
 
Labcorp (LH) delivered earnings and revenue surprises of +2.80% and +1.13%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?...
28.10.26 - 12:42
ROUNDUP: Labcorp Boosts FY26 Outlook (AFX)
 
WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Wednesday, life sciences company Labcorp Holdings, Inc. (LH) raised its adjusted earnings and revenue guidance for......
28.10.26 - 12:18
Labcorp Holdings Inc. Announces Rise In Q3 Profit (AFX)
 
WASHINGTON (dpa-AFX) - Labcorp Holdings Inc. (LH) revealed a profit for its third quarter that Increases, from the same period last yearThe company's bottom line came in at $262.8 million, or $3.2......
28.10.26 - 11:54
Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance (PR Newswire)
 
Results from operations for third quarter 2026 versus third quarter 2025:Revenue: $3.81 billion vs. $3.56 billion, up 6.9% Diluted EPS: $3.22 vs. $3.12, up 3.3% Adjusted EPS: $4.78 vs. $4.18, up 14.5% Raised full-year enterprise revenue growth and adjusted EPS guidance:Revenue growth......
28.10.26 - 11:54
Labcorp Holdings Non-GAAP EPS of $4.78 beats by $0.14, revenue of $3.81B beats by $50M, raises FY guidance (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.10.26 - 18:48
Labcorp Holdings Q3 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.10.26 - 18:45
Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests (Zacks)
 
WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer screening....
23.10.26 - 15:18
Waters, Labcorp Partner To Expand Access To HPV Screening Test (AFX)
 
WASHINGTON (dpa-AFX) - Life sciences and diagnostics company Waters Corp. (WAT) announced on Friday that it has partnered with laboratory services provider LabCorp Holdings Inc. (LH) to expand acc......
23.10.26 - 14:03
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026 (PR Newswire)
 
Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center, and at-home settings Through a network serving more than 850,000......
22.10.26 - 22:33
Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential (PR Newswire)
 
Research collaboration aims to strengthen the science used to assess whether new medicines could be abused, supporting safer drug development and more informed regulatory decisions BURLINGTON, N.C., Oct. 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and......
21.10.26 - 20:37
Greenberg Traurig Advises OPKO Health on $722M+ Agreement to Sell Select BioReference Health Assets to Labcorp (PR Newswire)
 
MIAMI, Oct. 21, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised OPKO Health, Inc., a multinational biopharmaceutical company, on its agreement to sell select assets of its wholly owned subsidiary, BioReference Health, LLC, to Labcorp. The purchase price for the......
21.10.26 - 16:45
Labcorp Prepares to Report Q3 Earnings: What′s in the Cards? (Zacks)
 
LH's Q3 earnings may benefit from strong diagnostics demand, specialty testing expansion and acquisitions, with revenues projected to grow 5.7%....
21.10.26 - 13:00
Labcorp Holdings declares $0.72 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.10.26 - 12:57
Labcorp Declares Quarterly Dividend (PR Newswire)
 
BURLINGTON, N.C., Oct. 21, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable......
20.10.26 - 16:00
Labcorp To Buy Myriad Genetics′ Prenatal Testing Business For $210 Mln (AFX)
 
WASHINGTON (dpa-AFX) - Laboratory services provider LabCorp Holdings Inc. (LH) announced on Tuesday that it has agreed to acquire the Prenatal Health testing business of molecular diagnostics comp......
20.10.26 - 15:33
Myriad to sell prenatal health testing business to Labcorp for $210M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wie man einen Knaben gewöhnt, so läßt er nicht davon, wenn er alt wird. - Altes Testament: Spruch
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!